BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 35730485)

  • 1. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer.
    Zhang X; Li F; Zhou Y; Mao F; Lin Y; Shen S; Li Y; Zhang S; Sun Q
    Cell Death Dis; 2021 Jun; 12(7):627. PubMed ID: 34145213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway.
    Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S
    Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ST8SIA6-AS1 facilitates hepatocellular carcinoma progression by governing miR-651-5p/TM4SF4 axis.
    Mou Y; Ding X
    Anticancer Drugs; 2022 Sep; 33(8):741-751. PubMed ID: 35946523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
    Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y
    J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
    Chen Z; Huang J; Feng Y; Li Z; Jiang Y
    J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
    Guo C; Zhang M; Jin X; Zhu C; Qian J; Tao M
    Cell Biochem Funct; 2024 Jun; 42(4):e4020. PubMed ID: 38702967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression.
    Zhang X; Xu S; Hu C; Fang K; Zhou J; Guo Z; Zhu G; Li L
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1039-1047. PubMed ID: 33012505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
    Yu H; Wu Y; Huang J; Li S
    Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.
    Li Y; Jiang A
    Cancer Biol Ther; 2020 Jul; 21(7):647-655. PubMed ID: 32420798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
    Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
    Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
    Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression.
    Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q
    Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ST8SIA6-AS1 promotes colorectal cancer cell proliferation, migration and invasion by regulating the miR-5195/PCBP2 axis.
    Huang CM; Cao GY; Yang CX; Chen Y; Liu GD; Xu BW; Zhang X
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4203-4211. PubMed ID: 32373956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PSMA3-AS1 activates the progression of triple-negative breast cancer cells by blocking miR-186-5p-mediated PSME3 inhibition.
    Peng M; Yuan H
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):81-87. PubMed ID: 38279473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.